at the M.D. Anderson Hospital and Tumor Institute and the National Cancer Institute. She is an IOM member.

Timothy B. Baker, Ph.D., is a Professor of Medicine in the University of Wisconsin School of Medicine and Public Health. His principal research goals are to increase understanding of the motivational bases of addictive disorders and to develop and evaluate treatments for such disorders. He is also highly interested in developing and using technological and methodological advances to deliver and evaluate treatments for addictive disorders and cancer. Dr. Baker has served as the editor of the Journal of Abnormal Psychology, is the Principal Investigator of the University of Wisconsin Transdisciplinary Tobacco Use Research Center award (NCI/NIDA), has a K05 Senior Scientist Award from NCI, and is the recipient of the James McKeen Cattell Award from the Association for Psychological Science.

Rebecca Bascom, M.D., M.P.H., is a professor of medicine at the Milton S. Hershey Medical Center at Penn State University. Her areas of expertise include lung diseases and inhalation toxicology. Dr. Bascom led an analysis team to evaluate the cardiorespiratory health effects on New York City police officers exposed during the 9/11 terrorist attack. She has served on three National Research Council committees, the Committee on the Evaluation of the Department of Defense Comprehensive Clinical Evaluation Protocol, the Committee on Occupational Safety and Health in Research Animal Facilities, and the Committee on Health Effects of Indoor Allergens. Dr. Bascom earned her M.D. from the University of Oregon Health Sciences Center and her M.P.H. in occupational medicine from the Johns Hopkins Bloomberg School of Public Health. She trained in internal medicine, as well as pulmonary and critical care medicine at the Johns Hopkins Hospital.

Shyam Biswal, Ph.D., is Professor at the Department of Environmental Health, Division of Toxicology at the Johns Hopkins University Bloomberg School of Public Health. He also has a joint appointment in the Department of Oncology, Pulmonary and Critical Care Division, Johns Hopkins University School of Medicine. Dr. Biswal was a Research Associate, Division of Pharmacology and Toxicology, at the College of Pharmacy, University of Texas at Austin. Dr. Biswal did his postdoctoral research in the same department, and he has a Ph.D. in biotechnology from the Indian Institute of Technology. Dr. Biswal studies the mechanisms of gene-environment interactions and susceptibility to environmental lung diseases involving tobacco smoke exposure, such as COPD and lung cancer. His group has identified that transcription factor, Nrf2, is a critical modifier of inflammation

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement